MX2020001356A - Composiciones farmaceuticas. - Google Patents

Composiciones farmaceuticas.

Info

Publication number
MX2020001356A
MX2020001356A MX2020001356A MX2020001356A MX2020001356A MX 2020001356 A MX2020001356 A MX 2020001356A MX 2020001356 A MX2020001356 A MX 2020001356A MX 2020001356 A MX2020001356 A MX 2020001356A MX 2020001356 A MX2020001356 A MX 2020001356A
Authority
MX
Mexico
Prior art keywords
sup
pharmaceutical compositions
active ingredient
compositions
medicine
Prior art date
Application number
MX2020001356A
Other languages
English (en)
Inventor
John Pethen Stephen
Cook Gary
Louise Marsh Sally
Bryan Roe Michael
Martyn Yea Christopher
Original Assignee
Kalvista Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1713660.7A external-priority patent/GB201713660D0/en
Application filed by Kalvista Pharmaceuticals Ltd filed Critical Kalvista Pharmaceuticals Ltd
Publication of MX2020001356A publication Critical patent/MX2020001356A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con composiciones farmacéuticas en solución acuosa que comprenden por lo menos un agente de tonicidad no iónico, por lo menos una solución tampón y un ingrediente activo, caracterizadas porque dicho ingrediente activo es un compuesto de la fórmula I (ver Fórmula) caracterizado porque R1-R9 están definidos en el presente documento; los procesos para la preparación de estas composiciones y su uso en medicina, en especial su uso en el tratamiento de las enfermedades oculares.
MX2020001356A 2017-08-11 2018-08-13 Composiciones farmaceuticas. MX2020001356A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762544346P 2017-08-11 2017-08-11
GBGB1713660.7A GB201713660D0 (en) 2017-08-25 2017-08-25 Pharmaceutical compositions
PCT/GB2018/052292 WO2019030540A1 (en) 2017-08-11 2018-08-13 PHARMACEUTICAL COMPOSITIONS

Publications (1)

Publication Number Publication Date
MX2020001356A true MX2020001356A (es) 2020-03-20

Family

ID=70976595

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020001356A MX2020001356A (es) 2017-08-11 2018-08-13 Composiciones farmaceuticas.

Country Status (8)

Country Link
CL (1) CL2020000356A1 (es)
CO (1) CO2020002287A2 (es)
EC (1) ECSP20017939A (es)
IL (1) IL272428A (es)
MX (1) MX2020001356A (es)
PH (1) PH12020500246A1 (es)
RU (1) RU2020109955A (es)
UA (1) UA125537C2 (es)

Also Published As

Publication number Publication date
IL272428A (en) 2020-03-31
PH12020500246A1 (en) 2021-03-15
UA125537C2 (uk) 2022-04-13
CL2020000356A1 (es) 2020-06-19
CO2020002287A2 (es) 2020-06-09
RU2020109955A3 (es) 2022-01-24
RU2020109955A (ru) 2021-09-14
ECSP20017939A (es) 2020-04-22

Similar Documents

Publication Publication Date Title
ECSP19030002A (es) 1,2,4-triazolonas 2,4,5-trisustituidas
MX2022010520A (es) Macrociclos peptidicos contra acinetobacter baumannii.
MX2021004707A (es) Nuevos compuestos antihelminticos.
MX2023005636A (es) Inhibidores de bcl6 derivados de bencimidazolona.
MX2020001403A (es) Nuevos derivados de quinolina.
NZ708593A (en) Novel pyrazole derivative
TN2017000467A1 (en) Amido-substituted cyclohexane derivatives
MX2016013529A (es) Derivados de amidas y sales farmaceuticamente aceptables de los mismos, método de preparación de los mismos y aplicación médica de los mismos.
PE20191650A1 (es) Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue
MX2020001404A (es) Dihidrooxadiazinonas.
PH12016501357B1 (en) Pharmaceutical preparation containing pyridylaminoacetic acid compound
MX2020011873A (es) Nuevos derivados de quinolina.
EA201591541A1 (ru) Ингибиторы бета-секретазы 1 (bace 1)
CL2020002252A1 (es) Formulación oftálmica.
MX2021006969A (es) Ligante peptidico.
PH12019502150A1 (en) Compounds and methods for the treatment of parasitic diseases
EA202191684A1 (ru) Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
MX2023006235A (es) Composiciones para administracion de farmacos y metodos de uso de las mismas.
EP4234021A3 (en) Pharmaceutical composition comprising an adenosine derivative for use in the prevention or treatment of diabetic nephropathy
PH12019502652A1 (en) 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases
EA202190316A1 (ru) Конденсированное производное лактама
MX2022006502A (es) Composiciones farmaceuticas.
EA202191683A1 (ru) Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии
MY197518A (en) Preventive and/or therapeutic agent of immune disease